HB 1175, titled the Affordability in Healthcare Act, is a broad healthcare cost and market-structure bill aimed at lowering premiums, improving transparency, and increasing competition across North Carolina’s healthcare system. It directs the Department of Health and Human Services to establish a statewide low-cost health plan option on the ACA marketplace, with affordability targets for premiums, administrative costs, and out-of-pocket spending, and allows the State to use reference-based reimbursement and other procurement tools to keep prices down. The bill also creates a Public Health Purchasing Consortium to coordinate purchasing by state and local public entities, with shared data standards, model procurement rules, and annual reporting on savings and outcomes.
The bill further expands state spending on health-related social needs and chronic disease prevention by appropriating funds to continue and expand Healthy Opportunities Pilots activities. It also strengthens hospital and ambulatory surgical facility price transparency by requiring more detailed reporting of charges, negotiated rates, Medicare and Medicaid reimbursement, and procedure-level cost data, along with patient-requested written disclosures. In addition, it adds new protections around provider billing and collections, including fair notice requirements for out-of-network care, a right to a good-faith estimate for shoppable services, limits on final bills relative to estimates, and restrictions on facility fees for certain outpatient services.
HB 1175 also revises insurance utilization review and prior authorization rules. It shortens or clarifies timelines for prior authorization decisions, requires more detailed appeal and grievance notices, limits the use of artificial intelligence as the sole basis for denial, and requires insurers to maintain current prior authorization requirements on their websites. The bill applies similar utilization review expectations to the State Health Plan and adds a federal API compliance requirement for prior authorization by 2028. These provisions are intended to reduce administrative friction for patients and providers while making coverage decisions more transparent and timely.
A major portion of the bill focuses on healthcare market consolidation and rural access. It eliminates certificate-of-need review for inpatient rehabilitation facilities, rehabilitation beds, and related services, while creating a new rural health services review process that requires advance notice and state review of material changes affecting essential rural services. The bill also creates a new state review regime for hospital sales, transfers, mergers, and other transactions, giving the State Auditor, Attorney General, and State Treasurer authority to review, object to, or seek injunctions against hospital transactions that may harm competition, charitable assets, or access to care. It includes post-transaction reporting, financial assistance notice requirements, and penalties for noncompliance.
No committee debate or recorded votes were provided, so the overall sentiment must be inferred from the bill text itself. The bill is framed as a consumer- and patient-protection measure, with repeated findings emphasizing affordability, transparency, competition, and rural access. Likely points of contention include the scope of state intervention in private healthcare markets, the use of reference-based reimbursement, the new hospital transaction review authority, the elimination of certificate-of-need review for rehabilitation services, and the administrative and compliance burdens imposed on insurers, hospitals, and acquiring entities. Supporters would likely favor the bill’s cost-control and transparency goals, while opponents may argue it expands regulation and state oversight too far.
The bill would make extensive changes to Chapters 58, 131E, 143, and 147 of the North Carolina General Statutes. It creates new state programs and oversight structures, including a low-cost ACA marketplace plan option, a public purchasing consortium, a rural health services review process, and a hospital transaction review regime. It also amends insurance, billing, transparency, and utilization review laws to impose new disclosure, reporting, prior authorization, and appeal requirements on insurers, hospitals, ambulatory surgical facilities, and health systems. The bill appropriates recurring and nonrecurring General Fund money for implementation and for Healthy Opportunities Pilots expansion, and it authorizes civil penalties, injunctive relief, and other enforcement mechanisms for violations.
No committee transcripts or votes were provided, so there is no recorded legislative debate to summarize. Based on the bill’s findings and structure, the measure is clearly presented as a pro-affordability, pro-transparency, and pro-consumer healthcare reform package. The text suggests a policy direction favoring stronger state intervention to reduce costs, improve access, and protect rural and uninsured patients, which would likely appeal to supporters of healthcare regulation and consumer protections. At the same time, the breadth of the bill indicates it would likely draw resistance from insurers, hospitals, health systems, and other stakeholders affected by tighter oversight and new reporting obligations.
The most likely areas of contention are the bill’s expanded state authority over healthcare pricing, insurance utilization review, and hospital transactions. Hospitals and health systems may object to the new facility-fee limits, good-faith estimate requirements, transparency mandates, and the broad review power over mergers, acquisitions, and other ownership changes. Insurers and utilization review organizations may oppose the shortened prior authorization timelines, limits on AI-based denials, and the requirement to keep website disclosures current. Rural providers and hospital systems could also be concerned about the new notice-and-review process for material changes, while supporters are likely to emphasize the bill’s protections for patients, rural access, and competition.